Zee Business Managing Editor Anil Singhvi said that Laurus Labs is expected to post strong quarterly numbers on 29th April. Market Expert, Rakesh Bansal said that ahead of results, this stock can be purchased with stop-loss of Rs 433.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

See Zee Business Live TV Streaming Below:

Research analyst Ashish Chaturvedi said that Laurus Labs is into the business of Formulations, API and synthesis. The Formulation Business is likely to see growth of 77% (YoY) while API Business will witness growth of 90% (YoY).  Ashish said that the Synthesis segment will also likely see a growth of 37% (YoY). All the three segments of the company will perform strongly in Q4 FY21, says Ashish.

Ashish said that the Profit of the company is expected to rise by 150% and come at Rs 275 cr (YoY). Topline (Revenue / Sales) is expected to improve by 49% and come at Rs 1250 cr. The EBITDA Margins are expected to come at 32% from 23% (YoY). Operational efficiency will improve the EBITDA, which is expected to come at Rs 400 cr, up 108% (YoY).